Ghk-cu is the specific, most extensively studied example within that category
Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
Considering these factors, we strongly encourage patients interested in vitamin B12 injections to schedule a consultation with our experienced healthcare professionals
Serious risks, including kidney strain, liver issues, allergic reactions, and rare cases of Stevens-Johnson syndrome, are linked to high doses, counterfeit vials, and unsupervised administration
Patients should be counseled that current evidence supporting peptides is largely preclinical, that human surgical outcomes are poorly studied, and that product purity and sterility cannot be assumed